|
Zantac In Plastic ContainerDrug - Zantac In Plastic Container The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Ranitidine Hydrochloride
Strength -
EQ 50MG BASE/100ML
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
019593
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Dec 17, 1986
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Zantac In Plastic Container
Ranitidine Hcl Eq 150mg Base Capsule; Oral
Ranitidine Hcl Eq 300mg Base Capsule; Oral Zantac 150 Eq 150mg Base Capsule; Oral Zantac 300 Eq 300mg Base Capsule; Oral Zantac 150 Eq 150mg Base/packet Granule, Effervescent; Oral Ranitidine Eq 25mg Base/ml Injectable; Injection Ranitidine Hcl Eq 25mg Base/ml Injectable; Injection Zantac Eq 25mg Base/ml Injectable; Injection Zantac In Plastic Container Eq 1mg Base/ml Injectable; Injection Zantac In Plastic Container Eq 50mg Base/100ml Injectable; Injection NewDrugInformation |